Real-World-Daten zur Verwendung von Certolizumab Pegol bei axialer Spondyloarthritis in der klinischen Praxis in Europa: 24-Wochen-Ergebnisse einer prospektiven, nicht-interventionellen Kohortenstudie

Authors
Publication date
5 February 2019
Publisher
German Medical Science GMS Publishing House; Düsseldorf
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      German Medical Science

      redirect
      oaioai:oai-gms.dimdi.de:GM18dgrh1...
      Last time updated on 09/07/2019